Distinct Type 1 Immune Networks Underlie the Severity of Restrictive Lung Disease after COVID-19

Scientists analyzed hundreds of cellular and molecular features in the context of discrete pulmonary phenotypes to define the systemic immune landscape of post-COVID lung disease.